The Valley Desk

Clinical trial reportJournal of clinical oncology : official journal of the American Society of Clinical OncologyPublished

Final Overall Survival Analysis of S1500: A Randomized, Phase II Study Comparing Sunitinib With Cabozantinib, Crizotinib, and Savolitinib in Advanced Papillary Renal Cell Carcinoma

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names University of Pennsylvania. Affiliation source

Publication record

Type
Clinical trial report
Venue
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published
Subject terms
Humans; Carcinoma, Renal Cell; Carcinoma, Papillary; Kidney Neoplasms; Anilides; Pyrazines; Pyridines; Triazines; Antineoplastic Combined Chemotherapy Protocols; Neoplasm Staging; Survival Analysis; Adult
PubMed ID
39255440
PubMed Central ID
PMC11575905
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal